PEPTIDETACTICS

RESEARCH

HPLC analysis of peptides

Reversed-phase HPLC is the default method for assessing synthetic peptide purity. Understanding how the separation works makes the difference between reading a chromatogram and simply accepting the number printed underneath it.

How reversed-phase separation works

In reversed-phase chromatography the stationary phase is non-polar — typically silica with bonded C18 alkyl chains — and the mobile phase is polar. Analytes partition between the two, and more hydrophobic species interact more strongly with the stationary phase and elute later.

For peptides, hydrophobicity is determined mainly by side-chain composition. Peptides rich in leucine, isoleucine, phenylalanine and tryptophan retain longer; those rich in charged and polar residues such as aspartate, glutamate, lysine and arginine elute earlier.

Peptides are almost always run under gradient conditions rather than isocratic ones, because the range of hydrophobicity across the species in a single sample is too wide for a fixed mobile phase composition to resolve.

The role of ion-pairing agents

Peptide reversed-phase methods generally include an acidic ion-pairing agent, most commonly trifluoroacetic acid at around 0.1%.

It performs two jobs at once. The low pH suppresses ionisation of acidic side chains, and the trifluoroacetate anion pairs with positively charged basic side chains, masking their charge. Both effects increase the effective hydrophobicity of the peptide and produce sharper, more symmetrical peaks.

Formic acid is sometimes substituted where the method is coupled to mass spectrometry, because TFA suppresses electrospray ionisation. That substitution usually costs some peak shape, which is a routine trade-off between chromatographic resolution and mass spectrometric sensitivity.

Parameters that change the result

A purity figure is a property of the method as much as of the sample. Changing any of the following can change the number.

  • Gradient slope — shallower gradients generally improve resolution of closely eluting impurities but lengthen the run.
  • Column chemistry, particle size and pore size — wide-pore packings are typically used for larger peptides.
  • Column temperature — affects both selectivity and peak shape.
  • Detection wavelength — determines which species are detected at all.
  • Sample load — overloading broadens peaks and can hide small impurities under the main peak.
  • Integration parameters — where the baseline is drawn and how peaks are split directly changes the reported percentage.

Reading a peptide chromatogram

The first thing to look at is not the main peak but the baseline. A noisy or drifting baseline makes small impurity peaks unresolvable from noise and undermines any integration performed on top of it.

Peak shape carries diagnostic information. Tailing often indicates secondary interactions with the stationary phase or column degradation; fronting frequently indicates sample overload. A shoulder on the main peak suggests a co-eluting impurity that the method has not fully resolved.

Where the run ends also matters. If the gradient finishes before strongly retained species have eluted, they are simply absent from the integration, and the reported purity is correspondingly optimistic. A chromatogram that stops immediately after the main peak should prompt a question about what came afterwards.

Why HPLC is not sufficient on its own

Chromatography separates; it does not identify. A single symmetrical peak establishes that the sample is dominated by one species under those conditions, but it says nothing about which species that is.

It is entirely possible for a chromatographically pure sample to be the wrong peptide. Pairing chromatography with mass spectrometry is what closes that gap, which is why both appear on a well-constructed certificate.

Frequently asked questions

Why is TFA used in peptide HPLC?
Trifluoroacetic acid acts as an ion-pairing agent. Its low pH suppresses ionisation of acidic side chains, and the trifluoroacetate anion pairs with basic side chains. Together these effects increase effective hydrophobicity and produce sharper, more symmetrical peaks.
Can two laboratories report different purity for the same sample?
Yes, and legitimately so. Gradient slope, column chemistry, temperature, detection wavelength, sample load and integration practice all affect the result. This is why a purity figure is only interpretable alongside the method that produced it.
What does a shoulder on the main peak indicate?
Usually a co-eluting impurity that the method has not fully resolved — often a closely related species such as a deletion sequence or an oxidation product. A shallower gradient or different column chemistry may separate it.

Sources and further reference

Compounds this applies to

The considerations above are not abstract. Each of these compounds is listed in the Peptide Tactics catalog for research use in India, with its reference data, analytical notes and documentation status set out in full.

BPC-157

BPC-157 is a synthetic pentadecapeptide — a chain of fifteen amino acids — corresponding to a partial sequence of the gastric peptide referred to in the literature as body protection compound. It is listed here as a research catalog item with the compound reference data recorded in public chemical databases.

View listing and pricing

MOTS-c

MOTS-c is a 16-residue mitochondrial-derived peptide. It is unusual among the peptides in this catalog because it is encoded within the mitochondrial genome rather than the nuclear genome, in an alternative open reading frame inside the 12S ribosomal RNA gene.

View listing and pricing

GHK-Cu

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. Unlike the other entries in this catalog it is a metal-peptide complex rather than a peptide alone, which changes how it is described, handled and analysed.

View listing and pricing

See the full research peptide catalog, the India sourcing guide or how to request documentation.

Continue reading